Pfentech

01 / THE IDEA

What they’re building

Pfentech has built an AI-powered T-cell receptor design platform for cancer, infectious and autoimmune disease.

• UCL’s “Most Promising Startup”, 2025
• Up to 700× faster than the gold standard at designing a full TCR panel
• LOI from a top global pharma company
• Binders to cancerous targets designed and validated

02 / THE PEOPLE

The team behind it

Isaac Pfaender

CEO · Resident

UCL Computer Science, TCR research funded by Google DeepMind

Bailey Costello

LinkedIn ↗

COO · Resident

UCL Physics graduate, serial startup pitch prize winner

03 / IN THE NEWS

Latest from Pfentech